Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/8/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Fred N. Eshelman

Wrong Dr. Fred N. Eshelman?


Furiex Pharmaceuticals, Inc.
3900 Paramount Parkway Suite 150
Morrisville, North Carolina 27560
United States

Company Description: Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) is a drug development collaboration company that uses innovative clinical development design to accelerate and increase...   more

Employment History

Board Memberships and Affiliations


  • Pharm.D.
  • bachelor's degree , pharmacy
    University of North Carolina at Chapel Hill
  • doctorate , pharmacy
    University of Cincinnati
  • PharmD
180 Total References
Web References
"We are pleased that Takeda ..., 7 Mar 2014 [cached]
"We are pleased that Takeda has taken this important step in seeking approval of trelagliptin succinate in Japan," said Fred Eshelman, Pharm.D., chairman of Furiex.
Board of Directors, 2 Jan 2014 [cached]
Fred Eshelman, Pharm.D.
Fred Eshelman, Pharm.D., is Furiex's founding chairman. He was the founder and executive chairman of Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) prior to its sale to private equity.
Furiex Chairman Fred ..., 30 May 2014 [cached]
Furiex Chairman Fred Eshelman
Its a deal that, if eluxadoline is approved by the Food and Drug Administration, could mean$356 million to Furiex founder and North Carolina pharma vet Fred Eshelman, who owns more than 2.8 million shares. And it's the second big deal for Eshelman, who also founded Pharmaceutical Product Development (PPD), which went public in 1996, then private for $3.9 billion in 2011.
Princeton BioPharma Capital Partners, LLC, 15 Oct 2014 [cached]
Fred Eshelman, Pharm D
Dr. Eshelman was the founder, CEO and Chairman of PPD, one of the world's largest contract research organizations. The company was recently sold for $3.9 billion to Carlyle Group. Dr. Eshelman was also a board member of Aton Pharma and now serves as the founding Chairman of Furiex Pharmaceuticals (NASDAQ: FURX).
In 2008, The School of Pharmacy at the University of North Carolina at Chapel Hill was named after Dr. Eshelman who graduated from the school in 1972.
State Chapter Steering Committee Members - Fix The Debt, 10 July 2014 [cached]
Fred Eshelman, former CEO, PPD Pharmaceuticals
Other People with the name "Eshelman":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.